RxDoctor Payments Data

Alfred Daniels, MD

Family Medicine · McClellanville, SCNPI 1174607360

Payments from drug & device makers

$507in general payments, 2019–2025

Across 29 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$121
  • Corcept Therapeutics$47
  • Pfizer$47
  • Mylan Specialty L.p.$46
  • Xeris Pharmaceuticals, Inc.$41
  • Sanofi-aventis U.S. LLC$40
  • plus $165 from 9 others

What the payments were for

  • Food & beverage$49698%
  • Education$122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$507 in reported general payments places this provider in the 50th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$4,350
Medicare patients
80
Services billed
210

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin109$125,805
OzempicSemaglutide86$102,096
TrulicityDulaglutide44$52,809
EliquisApixaban55$45,774
EntrestoSacubitril/Valsartan29$31,674
FarxigaDapagliflozin Propanediol39$30,670
JanuviaSitagliptin Phosphate31$21,243
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$14,223
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$13,949
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$11,871
Lantus SolostarInsulin Glargine,hum.Rec.Anlog91$11,032
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl84$8,796
LinzessLinaclotide14$8,719
MyrbetriqMirabegron11$5,083
Buprenorphine12$4,186

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$13$102,09686 claims
Lilly USA, LLCTrulicity$14$52,80944 claims
PfizerEliquis$47$45,77455 claims
NovartisEntresto$14$31,67429 claims
AstraZenecaFarxiga$121$30,67039 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in McClellanville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →